封面
市場調查報告書
商品編碼
2051234

臨床營養市場:按營養類型、應用、年齡層、分銷管道和地區分類

Clinical Nutrition Market, By Nutrition Type, By Application, By Age Group, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

臨床營養市場預計2026年達到139.7億美元,預計2033年將達到212.8億美元。預計從2026年到2033年,其複合年成長率將達到6.2%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 139.7億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.20% 2033年市場規模預測: 212.8億美元

臨床營養是指為患有急性疾病、營養不良或需要調整日常飲食的特定疾病的患者提供的專業營養支持。這包括評估、診斷、介入和監測患者的營養需求。臨床營養有助於管理影響飲食攝取和營養吸收的各種疾病,例如癌症、神經系統疾病、胃腸道疾病、傷口和創傷。它在減少疾病併發症、促進癒合過程以及改善患者治療效果和縮短復原時間方面也發揮著至關重要的作用。過去十年,全球慢性病盛行率的不斷上升和人口老化導致對專業臨床營養的需求日益成長。

市場動態

全球臨床營養市場的成長主要受以下因素驅動:老年人口增加、慢性病和文明病盛行率上升、居家照護和醫療保健機構對營養產品的需求不斷成長,以及嬰幼兒營養研發機構的推出。然而,臨床營養療法認知度低和嚴格的法規結構等因素限制市場成長。基於個體基因譜的個人化營養產品的開發為市場參與企業創造了新的機會。此外,經腸營養和腸外營養在腫瘤學和神經病學等新興治療領域的應用研究進展也展現出廣闊的前景。

例如,今年10月,有機嬰兒配方奶粉生產商Bobbie Baby宣布正式推出Bobbie Labs,這是一個專注於嬰兒營養的研發中心。 Bobbie Labs是該公司承諾在2030年投資1億美元,以改善美國每個家庭嬰兒配方奶粉的可及性、品質和選擇的關鍵組成部分。

本次調查的主要特點

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數,對全球臨床營養市場的主要參與者進行了分析。
  • 本研究涵蓋的主要公司包括 Abbott、Baxter、Fresenius SE & Co. KGaA、Persan Pharma、Lonza、B. Braun SE、Nestlé、Danone SA、Perigo Company plc、 BASF SE、Reckitt Benckiser Group PLC 和 Otsuka Pharmaceutical Co., Ltd.。
  • 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球臨床營養市場報告的目標對象包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以利用各種用於分析全球臨床營養市場的策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球臨床營養市場:依營養類型分類,2021-2033年

  • 經腸營養
  • 腸外營養

第5章 全球臨床營養市場:依應用領域分類,2021-2033年

  • 癌症
  • 代謝性疾病
  • 消化系統疾病
  • 神經病變
  • 其他

第6章 全球臨床營養市場:依年齡層別分類,2021-2033年

  • 成人
  • 兒童
  • 老年人

第7章 全球臨床營養市場:依通路分類,2021-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 全球臨床營養市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 印度
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • Abbott
  • Baxter
  • Fresenius SE & Co. KGaA
  • Persanfarma
  • Lonza
  • B.Braun SE
  • Nestle
  • Danone SA
  • Perrigo Company plc
  • BASF SE
  • Reckitt Benckiser Group PLC.
  • Otsuka Pharmaceutical Co., Ltd.

第10章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI980

Clinical Nutrition Market is estimated to be valued at USD 13.97 Bn in 2026 and is expected to reach USD 21.28 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13.97 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.20% 2033 Value Projection: USD 21.28 Bn

Clinical nutrition refers to the specialized nutrition support provided to patients who are acutely ill and malnourished or have specific medical conditions requiring modifications to their usual diet. It involves the assessment, diagnosis, intervention, and monitoring of patients' nutritional needs. Clinical nutrition enables the management of various conditions like cancer, neurological disorders, gastrointestinal diseases, wounds, or injuries that impact dietary intake and nutrient absorption. It plays a vital role in reducing disease complications, supporting healing processes, and improving treatment outcomes and recovery times of patients. The widespread prevalence of chronic diseases and rising elderly population worldwide have increased the demand for specialized clinical nutrition over the past decade.

Market Dynamics

The growth of the global clinical nutrition market is driven by the rising geriatric population, increasing prevalence of chronic and lifestyle diseases, growing demand for nutritional products in homecare and healthcare settings, and the launch of research and development facilities for infant nutrition. However, factors like limited awareness regarding clinical nutrition therapy and stringent regulatory framework are restraining the market growth. The development of personalized nutritional products based on an individual's genetic profile is paving opportunities for market players. Also, growing research on using enteral and parenteral nutrition in new therapeutic areas like oncology and neurology presents a lucrative outlook.

For instance, in October, Bobbie Baby, an organic infant formula company, announced the official launch of Bobbie Labs, its research and development hub, dedicated to infant feeding. Bobbie Labs is a core element of the company's commitment to invest USD 100 million to increase infant formula access, quality, and options for all U.S. families by 2030.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global clinical nutrition market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Abbott, Baxter, Fresenius SE & Co. KGaA, Persanfarma, Lonza, B. Braun SE, Nestle, Danone S.A., Perrigo Company plc, BASF SE, Reckitt Benckiser Group PLC., and Otsuka Pharmaceutical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global clinical nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical nutrition market.

Market Segmentation

  • By Nutrition Type (Revenue, USD Bn, 2021 - 2033)
  • Enteral Nutrition
  • Parenteral Nutrition
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Cancer
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others
  • By Age Group (Revenue, USD Bn, 2021 - 2033)
  • Adult
  • Pediatric
  • Geriatric
  • By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Insights (Revenue, USD Bn, 2021 - 2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
  • Abbott
  • Baxter
  • Fresenius SE & Co. KGaA
  • Persanfarma
  • Lonza
  • B.Braun SE
  • Nestle
  • Danone S.A.
  • Perrigo Company plc
  • BASF SE
  • Reckitt Benckiser Group PLC.
  • Otsuka Pharmaceutical Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Clinical Nutrition Market, By Nutrition Type
    • Global Clinical Nutrition Market, By Application
    • Global Clinical Nutrition Market, By Age Group
    • Global Clinical Nutrition Market, By Distribution Channel
    • Global Clinical Nutrition Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Clinical Nutrition Market, By Nutrition Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Enteral Nutrition
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Parenteral Nutrition
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Clinical Nutrition Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Clinical Nutrition Market, By Age Group, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Clinical Nutrition Market, By Distribution Channel, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Clinical Nutrition Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius SE & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Persanfarma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • B.Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nestle
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danone S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Perrigo Company plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reckitt Benckiser Group PLC.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • Research Methodology
  • About us